文献速递肝病

肝细胞中的肿瘤进展位点2促进小鼠肝脏及全身代谢紊乱

Tumor Progression Locus 2 in Hepatocytes Potentiates Both Liver and Systemic Metabolic Disorders in Mice.
PubMed 文献 · Hepatology · 2018-05-15

在多种物种(人、猴、小鼠)的脂肪肝中TPL2蛋白表达显著升高;肝细胞特异性TPL2敲除小鼠在高脂饮食下糖脂紊乱改善、胰岛素敏感性保留、炎症减轻,而过表达则相反;机制上TPL2通过MKK7特异性激活JNK。

要点

  • 脂肪肝中TPL2蛋白表达在人类、猴和小鼠均显著升高。
  • 肝细胞TPL2敲除改善高脂饮食小鼠的糖脂失衡、胰岛素敏感性和炎症。
  • TPL2-MKK7-JNK信号轴是NAFLD及代谢紊乱的潜在可成药靶点。

核心结论

  • 肝细胞中TPL2作为关键介质,通过特异性增强MKK7-JNK激活促进肝脏及全身代谢紊乱。

研究设计与样本

  • 动物实验研究,比较肝细胞特异性TPL2敲除小鼠与野生型同窝对照在高脂饮食下的表型,并进行TPL2过表达实验。

主要发现

  • 与野生型同窝小鼠相比,肝细胞特异性TPL2敲除小鼠在高脂饮食下糖脂失衡改善、胰岛素敏感性保留、炎症减轻。
  • 肝细胞过表达TPL2导致相反的表型。
  • TPL2蛋白表达在人类、猴和小鼠的脂肪肝中均显著升高。

关键数值与推荐

  • MKK7被鉴定为TPL2激活JNK的特异性底物。
  • 肝细胞TPL2-MKK7-JNK信号被视为治疗NAFLD及相关代谢紊乱的有前景的可成药靶点。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Tumor progression locus 2 (TPL2), a serine/threonine kinase, has been regarded as a potentially interesting target for the treatment of various diseases with an inflammatory component. However, the function of TPL2 in regulating hepatocyte metabolism and liver inflammation during the progression of nonalcoholic fatty liver disease (NAFLD) is poorly understood. Here, we report that TPL2 protein expression was significantly increased in fatty liver from diverse species, including humans, monkeys, and mice. Further investigations revealed that compared to wild-type (WT) littermates, hepatocyte-specific TPL2 knockout (HKO) mice exhibited improved lipid and glucose imbalance, reserved insulin sensitivity, and alleviated inflammation in response to high-fat diet (HFD) feeding. Overexpression of TPL2 in hepatocytes led to the opposite phenotype. Regarding the mechanism, we found that mitogen-activated protein kinase kinase 7 (MKK7) was the specific substrate of TPL2 for c-Jun N-terminal kinase (JNK) activation. TPL2-MKK7-JNK signaling in hepatocytes represents a promising drugable target for treating NAFLD and associated metabolic disorders. Conclusion: In hepatocytes, TPL2 acts as a key mediator that promotes both liver and systemic metabolic disturbances by specifically increasing MKK7-JNK activation.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Gong J, Fang C, Zhang P, et al. Tumor Progression Locus 2 in Hepatocytes Potentiates Both Liver and Systemic Metabolic Disorders in Mice. Hepatology. 2018. PMID: 29381809. doi:10.1002/hep.29820

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。